LXRX
NASDAQ
$2.33
Lexicon Pharmaceuticals Inc (LXRX)
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $3.77 (+61.80%)
Market Cap
$937M
Revenue 5Y CAGR
+24.38%
Free Cash Flow Yield
-4.14%
Beta (5Y)
1.08
Price Chart
Valuation
Market Cap$937M
P/S13.52
P/B4.75
Profitability
Total Revenue (TTM)$70M
Gross Profit (TTM)$66M
EBITDA-$24M
Profit Margin-4.9%
Operating Margin-4.7%
EPS-$0.07
Financial Health
Debt-to-Equity24.5%
Free Cash Flow Yield-4.14%
Growth & Risk
Revenue 5Y CAGR+24.38%
FCF 5Y CAGR-23.30%
Beta (5Y)1.08
Sharpe Ratio1.03